These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19917634)

  • 1. Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration?
    Umegaki H
    Age Ageing; 2010 Jan; 39(1):8-10. PubMed ID: 19917634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes mellitus and cognition: is there a link?].
    Barrou Z; Lemaire A; Boddaert J; Verny M
    Psychol Neuropsychiatr Vieil; 2008 Sep; 6(3):189-98. PubMed ID: 18786878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration in diabetes mellitus.
    Umegaki H
    Adv Exp Med Biol; 2012; 724():258-65. PubMed ID: 22411248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
    Jellinger KA
    Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular pathologies and cognition in a population-based cohort of elderly people.
    Fernando MS; Ince PG;
    J Neurol Sci; 2004 Nov; 226(1-2):13-7. PubMed ID: 15537512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular risk factors and Alzheimer's disease.
    Cechetto DF; Hachinski V; Whitehead SN
    Expert Rev Neurother; 2008 May; 8(5):743-50. PubMed ID: 18457531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.
    Plastino M; Fava A; Pirritano D; Cotronei P; Sacco N; Sperlì T; Spanò A; Gallo D; Mungari P; Consoli D; Bosco D
    J Neurol Sci; 2010 Jan; 288(1-2):112-6. PubMed ID: 19836029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive dysfunction in patients with type 2 diabetes.
    Reijmer YD; van den Berg E; Ruis C; Kappelle LJ; Biessels GJ
    Diabetes Metab Res Rev; 2010 Oct; 26(7):507-19. PubMed ID: 20799243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience.
    Giannakopoulos P; Gold G; Kövari E; von Gunten A; Imhof A; Bouras C; Hof PR
    Acta Neuropathol; 2007 Jan; 113(1):1-12. PubMed ID: 17036244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia.
    Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
    Neurology; 2007 Mar; 68(12):927-31. PubMed ID: 17372128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral insulin and brain structure in early Alzheimer disease.
    Burns JM; Donnelly JE; Anderson HS; Mayo MS; Spencer-Gardner L; Thomas G; Cronk BB; Haddad Z; Klima D; Hansen D; Brooks WM
    Neurology; 2007 Sep; 69(11):1094-104. PubMed ID: 17846409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.
    Steffens DC; Potter GG; McQuoid DR; MacFall JR; Payne ME; Burke JR; Plassman BL; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):839-49. PubMed ID: 17623814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology.
    Thal DR; Schultz C; Botez G; Del Tredici K; Mrak RE; Griffin WS; Wiestler OD; Braak H; Ghebremedhin E
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):270-9. PubMed ID: 15885064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors.
    Reijmer YD; van den Berg E; de Bresser J; Kessels RP; Kappelle LJ; Algra A; Biessels GJ;
    Diabetes Metab Res Rev; 2011 Feb; 27(2):195-202. PubMed ID: 21294241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance in the brain: an old-age or new-age problem?
    Williamson R; McNeilly A; Sutherland C
    Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.